Kotak Institutional Equities upbeat on Cipla

CNBC-TV18 2019-02-19

Views 4

Currently, they prefer Cipla and Torrent pharma which have a strong domestic franchise underpinning the valuation and providing downside support. Cipla remains their top pick, said Chirag Talati, Associate Director, Kotak Institutional Equities

Share This Video


Download

  
Report form